Welcome to our dedicated page for Precision Optics news (Ticker: POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics stock.
Precision Optics Corporation (POCI) delivers cutting-edge optical solutions for medical, defense, and industrial applications. This news hub provides investors and industry professionals with essential updates on the company's strategic initiatives and market position.
Access official press releases, SEC filings, and operational announcements in one centralized location. Track developments across key areas including endoscopic imaging innovations, defense contract awards, and manufacturing capacity expansions. The repository includes earnings disclosures, regulatory updates, and partnership announcements critical for informed analysis.
Content is organized to highlight POCI's engineering advancements and quality-certified production processes. Users will find updates on the Unity Imaging Platform's clinical applications, custom optical device deployments, and compliance with medical device regulations.
Bookmark this page for streamlined access to Precision Optics' verified corporate communications. Combine regular monitoring with review of annual reports and investor presentations for complete market intelligence.
Precision Optics Corporation (NASDAQ: POCI) announced its participation in the Planet MicroCap Showcase: VEGAS 2023, taking place on April 26-27, 2023. Dr. Joe Forkey, the CEO, will present at the event, with a webcast of the presentation available at 7:00 PM ET on April 26. The presentation will also be archived for later viewing. In addition, the management team will hold one-on-one meetings at the conference venue in Las Vegas. For those interested in booking a meeting, they can contact the event organizers or email POCI directly.
Founded in 1982, Precision Optics specializes in advanced optical instruments for medical and defense applications. The company focuses on micro-optics and 3D imaging technologies, supporting minimally invasive surgeries and surgical robotic systems.
Precision Optics Corporation (NASDAQ: POCI), based in Gardner, Massachusetts, has announced a significant development order worth approximately $1.3 million for a next-generation urological endoscopy program. This order comes from a well-known medical device company and represents a strategic shift for Precision Optics, moving from a component supplier to a developer of complete endoscope imaging systems. The product development will be conducted in collaboration with Lighthouse Imaging, showcasing the company’s expertise in micro-optics, medical systems, and digital imaging. The agreement's completion is anticipated within the next 12 months, paving the way for potential future contracts.
CEO Joe Forkey emphasized that this agreement is a significant opportunity to enhance their role in medical imaging, supporting the increasing demand for integrated optics and electronics in next-generation products.
FAQ
What is the current stock price of Precision Optics (POCI)?
What is the market cap of Precision Optics (POCI)?
